日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas

一项针对复发性高级别星形细胞瘤患者的 I 期剂量递增研究,评估前体胱天蛋白酶激活化合物-1 与替莫唑胺联合用药的疗效

Holdhoff, Matthias; Nicholas, M Kelly; Peterson, Richard A; Maraka, Stefania; Liu, Li C; Fischer, James H; Wefel, Jeffrey S; Fan, Timothy M; Vannorsdall, Tracy; Russell, Meredith; Iacoboni, Michaella; Tarasow, Theodore M; Hergenrother, Paul J; Dudek, Arkadiusz Z; Danciu, Oana C

The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma.

PAC-1 与恩曲替尼联合治疗转移性葡萄膜黑色素瘤

Boudreau Matthew W, Tonogai Emily J, Schane Claire P, Xi Min X, Fischer James H, Vijayakumar Jayanthi, Ji Yan, Tarasow Theodore M, Fan Timothy M, Hergenrother Paul J, Dudek Arkadiusz Z

The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials

将弱势群体纳入务实性临床试验的伦理和监管环境

Welch, Mary Jane; Lally, Rachel; Miller, Jennifer E; Pittman, Stephanie; Brodsky, Lynda; Caplan, Arthur L; Uhlenbrauck, Gina; Louzao, Darcy M; Fischer, James H; Wilfond, Benjamin

Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics

妊娠期倍他米松:母体体重和多胎妊娠对药代动力学的影响

Della Torre, Micaela; Hibbard, Judith U; Jeong, Hyunyoung; Fischer, James H